The Gary Null Show - 06.14.22

Videos:

1. Assange Countdown: In Depth with Dr. George Szamuely (0:20)
2. Frank Zappa – 1979
3. Our freedom is under attack by those who care more for power than for the Constitution, the Bill of Rights & the American people. – Tulsi Gabbard (0:41)
4. Woody Allen speech from movie The Front (0:60)
5.  A Christian Response to Wokeness (FULL VIDEO) | Noelle Mering | Leadership Institute (21:51)
6.  NBC News just SMEARED real journalists in shameful hit piece | Redacted with Clayton Morris (22:00)
7. Propaganda disguised as education | Let’s talk about it – Riks (Start @ 0:58)

 

Nuts Increase Cognitive Scores Among Elderly Women

Harvard University and Brigham and Women’s Hospital, June 4th 2022 

Researchers from Harvard University and Brigham and Women’s Hospital have confirmed that eating more nuts every day will increase cognitive skills – at least among elderly women.

For six years, the researchers followed 16,010 women who 70 years old or older, and 15,467 completed the final cognitive interviews.

The researchers found those women who consumed five servings or more of nuts each week had higher scores on their cognitive testing compared to those who did not consume nuts. The average difference in scores was 0.08 units, which is equivalent to two years of cognition decline during the aging process.

The mechanism may be related to the fact that nuts are heart-healthy. And nut consumption has been associated with cardiovascular healthand mortality in other research.

Stress accelerates immune aging, study finds

University of Southern California, June 13, 2022

Stress—in the form of traumatic events, job strain, everyday stressors and discrimination—accelerates aging of the immune system, potentially increasing a person’s risk of cancer, cardiovascular disease and illness from infections such as COVID-19, according to a new USC study.

The research, published  in the Proceedings of the National Academy of Sciences (PNAS), could help explain disparities in age-related health, including the unequal toll of the pandemic, and identify possible points for intervention.

USC researchers decided to see if they could tease out a connection between lifetime exposure to stress—a known contributor to poor health—and declining vigor in the immune system.

As expected, people with higher stress scores had older-seeming immune profiles, with lower percentages of fresh disease fighters and higher percentages of worn-out white blood cells. The association between stressful life events and fewer ready to respond, or naive, T cells remained strong even after controlling for education, smoking, drinking, BMI and race or ethnicity.

CoQ10 supplementation associated with lower pro-inflammatory factors in randomized trial

Shahid Sadoughi University of Medical Sciences (Iran), June 8 2022. 

A double-blind trial reported in a recent issue of the International Journal of Vitamin and Nutrition Research found a reduction in markers of inflammation in mildly hypertensive patients given coenzyme Q10 (CoQ10) for twelve weeks. Participants who received CoQ10 also experienced an increase in adiponectin: a protein secreted by adipose tissue that has an anti-inflammatory effect and which has been found to be reduced in high blood pressure and cardiovascular disease.

“Considering that coenzyme Q10 has attracted noticeable attention in recent years for the treatment of cardiovascular diseases and hypertension in regard to its effect on inflammatory factors such as cytokines, it is therefore hypothesized that supplementation with coenzyme Q10 reduces the proinflammatory factors,” write Nasim Bagheri Nesami of Iran’s Shahid Sadoughi University of Medical Sciences and colleagues. “This study was conducted in order to determine the effects of coenzyme Q10 on proinflammatory factors as well as on adiponectin in patients with mild hypertension.”

Sixty men and women were randomized to receive 100 milligrams CoQ10 or a placebo for a twelve week period. Plasma adiponectin, high-sensitivity C-reactive protein (hs-CRP, a marker of inflammation) and the cytokines interleukin 2, interleukin6 and tumor necrosis factor-alpha were measured before and after treatment.

At the end of the study, participants who received CoQ10 had significant declines in interleukin-6 and hs-CRP compared with levels measured upon enrollment. They also experienced an increase in adiponectin, while levels in the placebo group slightly declined.

Probiotics prevent deadly complications of liver disease

Govind Ballabh Pant Hospital, New Delhi, India   June 6, 2022

Probiotics are effective in preventing hepatic encephalopathy in patients with cirrhosis of the liver, according to a new study in Clinical Gastroenterology and Hepatology. Hepatic encephalopathy is a deterioration of brain function that is a serious complication of liver disease.

“This rigorous new research finds that probiotics modify the gut microbiota to prevent hepatic encephalopathy in patients with cirrhosis of the liver,” said David W. Victor III, MD. “These results offer a safe, well-tolerated and perhaps cheaper alternative to current treatments.”

When comparing treatment with probiotics versus placebo, the researchers found that the incidence of hepatic encephalopathy was lower in patients treated with probiotics.  Probiotic supplementation was not associated with any side effects and none of the patients required discontinuation of therapy. These results suggest that probiotics are similar in effectiveness to the current standard of care, lactulose, in the prevention of hepatic encephalopathy, yet they appear to be much better tolerated. The effectiveness of lactulose, a nonabsorbable disaccharide, is limited by side effects (diarrhea, bloating and gas) and a narrow therapeutic window. 

Chelation therapy and vitamin supplements cut heart disease risk by over 25%

Columbia University, June 9, 2022 

A combination of high-dose multivitamins and chelation therapy may protect heart attack survivors from future cardiovascular events and death, according to a multicenter study published in the American Heart Journal.

Intravenous chelation, in which the chemical ethylenediaminetetraacetic acid (EDTA) is injected into the bloodstream in order to bind to minerals and help flush them from the body, is an FDA-approved treatment for heavy metal poisoning that was first used during World War I. 

“They’re all in our environment. Any of us who are of an age to have been exposed to leaded gasoline have lead in our bones. If we get an infusion of EDTA, we’ll have lead in our urine. It’s just the way it is. And as you get older and become osteoporotic, that lead starts getting released.”

In a randomized, double-blind trial, the researchers randomly assigned 1,708 stable heart attack survivors at 134 clinics across the United States to one of four experimental conditions: high-dose oral multivitamins plus chelation, chelation plus a vitamin-mimicking placebo, vitamins plus a chelation-mimicking placebo or double placebo. Participants had to get a 500 cc intravenous infusion once per week for 30 weeks, followed by another 10 infusions spaced two to eight weeks apart. All participants also had to take six large capsules daily.

The researchers found that chelation alone led to a statistically significant 18 percent reduction in primary endpoint, relative to placebo. Chelation plus multivitamins led to a 26 percent reduction in risk over placebo. Chelation plus multivitamin also reduced the secondary endpoint by 34 percent, compared with placebo.

Diabetic participants benefited even more dramatically. Among diabetics, chelation resulted in a 41 percent reduction in primary endpoint, while chelation plus vitamins resulted in a 51 percent reduction. The rate of all-cause mortality in diabetic patients dropped 43 percent with chelation alone, and the secondary endpoint was also reduced.

Natural Pain Killer With Powerful Ability to Remove Blood Clots and Dead Tissue

GreenMed Info, June 13th 2022 

Serrapeptase, also known as serratiopeptidase or serralysin, is a systemic enzyme, specifically it is a proteolytic enzyme. Serrapeptase was first derived from a species of bacteria found in the intestine of the silkworm. The bacteria, Serratia mercesans E1, produces serrapeptase to help breakdown the silkworm coccoon to free the silk moth.

A review study summarized that serrapeptase has immense applications in therapeutic areas which have been validated by several in vitro, in vivo, and clinical studies. “These applications are attributable to its versatile properties including anti-inflammatory, anti-biofilm, analgesic, anti-edemic, and fibrinolytic effects.”

Serrapeptase has been used for a wide range of health concerns: 

Serrapeptase for Joint Swelling

Serrapeptase is effective in reducing post-operative joint swelling in comparison to other therapies such as applying ice. 

Serrapeptase Dissolves Blood Clots, Dead Tissue, Biofilms

Anticoagulants and antiplatelet drugs are used for managing cardiovascular diseases but they are unable to dissolve an existing blood clot. Serrapeptase dissolves a fibrin clot within a blood vessel.  Studies have shown that serrapeptase can digest dead tissues, blood clots, cysts, biofilm and arterial plaques. 

Serrapeptase for Acute or Chronic Ear, Nose and Throat Conditions

The Journal of International Medical Research published the results of a study evaluating the efficacy and tolerability of serrapeptase using a double-blind, placebo-controlled study of 193 subjects suffering from acute or chronic ear, nose or throat disorders. Patients treated with serrapeptase reported significant symptom regression within 3 – 4 days. It was concluded that serrapeptase “has anti-inflammatory, anti-oedemic and fibrinolytic activity and acts rapidly on localized inflammation.” 

COVID-19 and Chronic Respiratory Conditions

A 2021 study, showed, “Proteolytic enzymes can be useful in the treatment of nosocomial, viral, and resistant infections, especially in pediatric and geriatric age groups due to its relative safety, less tolerance and resistance and its synergic effects.” 

Physicians have observed many COVID-19 cases with heart problems, kidney problems, and the presence of blood clots. Serrapeptase helps patients with chronic airway disease by reducing coughing and lessening viscosity of sputum. As a natural anticoagulant it interferes with platelet aggregation and the blood coagulation cascade. Serrapeptase has an anti-inflammatory impact on the tissue inflammation that contributes to the blood clot formation.